Senator Crapo Received National Cancer Advocacy Award
The American Cancer Society recognized Senator Mike Crapo for his recent leadership on cancer screening policy.
Updated on Sept. 24, 2026 in Cancer
Live Poll
Should the government prioritize expanding Medicare coverage for early-stage cancer detection screenings?
The American Cancer Society Cancer Action Network recently honored Senator Mike Crapo with the National Distinguished Advocacy Award. This recognition follows the passage of the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act.
Why it matters
The new legislation ensures that Medicare beneficiaries have access to critical early detection tests, aiming to reduce the mortality rate for cancers that previously lacked covered screening options.
Before the new law, approximately 70 percent of cancer deaths occurred in categories without covered screening tests. The policy aims to improve these outcomes by establishing a federal pathway for new diagnostics.
The players
Mike Crapo
Mike Crapo is a United States Senator representing Idaho who has been recognized for his legislative work in cancer policy.
American Cancer Society Cancer Action Network
This is the nonprofit advocacy affiliate of the American Cancer Society that focuses on influencing public policy to end cancer.
American Association for Cancer Research
The American Association for Cancer Research is a professional society dedicated to preventing and curing cancer through research, education, and communication.
The details
The Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act creates a framework for Medicare to cover multi-cancer screenings once they gain U.S. Food and Drug Administration approval. Additionally, lawmakers are working to reauthorize the Breast Cancer Education and Awareness Requires Learning Young Act to continue vital patient support through 2031.
Timeline
The Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act became law in February 2026.
The Senate Health, Education, Labor and Pensions Committee advanced the reauthorization of the EARLY Act in June 2026.
The American Association for Cancer Research published its 2026 Cancer Progress Report earlier this year.
The reauthorized Breast Cancer Education and Awareness Requires Learning Young Act is slated to run through 2031.
Health Landscape
The passage of the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act marks a major shift in federal oncology policy. This legislation modernizes Medicare standards to include advanced screening technologies, building on the foundation of previous cancer awareness programs.
This legislation will eventually allow Medicare beneficiaries access to advanced multi-cancer early detection tests that were previously uncovered. Patients should consult their healthcare providers as new screenings receive federal approval and enter the Medicare coverage pathway.
The takeaway
Legislative support for advanced screening technology is critical for improving long-term health outcomes for Medicare patients. Staying informed about new coverage approvals will be essential for those looking to utilize updated early detection tools as they become available.
What happens next
The Senate is currently processing the reauthorization of the Breast Cancer Education and Awareness Requires Learning Young Act, with an expected continuation through 2031.
Further reading
For more information on national legislative trends, visit the Cancer section.
Source note: This article includes information reported by U.S. Senate Finance Committee.
Live Poll
Should the government prioritize expanding Medicare coverage for early-stage cancer detection screenings?
